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ABSTRACT 
 
Cancer can be defined as unregulated cell growth.  This uncontrolled proliferation 
often stems from the disruption of transcriptional pathways.  Some cell cycle regulators 
have been well characterized, however the interaction between some important pathways 
have not been thoroughly studied in vivo. The relationship between the important tumor 
suppressor Retinoblastoma (Rb) and the E2F family has been studied extensively.  At the 
same time, c-Myc is a transcriptional activator that has been shown to be critical for proper 
proliferation, differentiation, and apoptosis.  While the Rb/E2F and c-Myc pathways are 
well defined individually, their interaction in vivo is unknown.  In this study, we first 
demonstrate that deletion of either E2f1-3 or c-Myc are able to rescue an Rb deficient 
phenotype.  Secondly, we show that combinatorial deletion of E2f1-3 and c-Myc reveal a 
subset of genes that are synergistically regulated by both E2f1-3 and c-Myc.  These results 
suggest that the pathways of these transcription factors overlap more than originally 
thought, and further analysis of transcriptional affiliation will be paramount to 
understanding carcinogenesis. 
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INTRODUCTION 
 
Retinoblastoma (Rb) is a tumor suppressor protein belonging to the pocket protein 
family, a group that also includes p107 and p130[1].  RB and the RB-like proteins are vital 
for normal cell division in mammals[2-3].  Most knowledge about RB’s role in cell division 
centers on its interaction with the E2F family of proteins.  There are currently eight known 
members of the E2f family[4-9].  E2f1, E2f2, and E2f3 are classified as activators, while 
E2f4-8 are classified as repressors (Figure 1)[4].  E2f activity is highly tissue and pathway 
dependent. For example, deletion of E2F1 and E2F2 can cause diabetes in mice[10].  
 
 Figure 1[4]. E2F family diagram.  Map of conserved or unique binding domains, 
dimerization domains, nuclear localization and export signals, as well as DNA binding 
domains across family members. 
 
 
RB antagonizes E2F1-3 by physically sequestering them in the nucleus[11-13].  RB’s 
ability to repress E2F1-3 activity is disrupted when it is phosphorylated by G1 regulated 
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cyclin dependent kinase (CDK) complexes[14-19]. Phosphorylation causes RB to release 
transcription factors E2F1-3, which then helps transition a cell into the DNA replication 
phase via transcription of their respective targets (Figure 2)[21].  Mutation or deletion of Rb 
allows this process to occur without check, and can ultimately lead to cancer[20].  RB 
deficiency has been identified in many types of cancer, adding to its importance in the 
search for cancer detection and treatment.   
 
 
Figure 2[21]. Rb/E2f pathway.  Rb represses E2f1-3 activity until it is phosphorylated by 
G1-CDK complexes.  Once released, E2f1-3 push a cell into S phase by promoting 
transcription of S-cyclins and positive feedback for it’s own transcription.  
 
 
 
The Myc family of transcription factors (c-Myc, N-Myc, L-Myc, S-Myc and B-Myc) 
has been observed to mediate multiple biological processes including cell growth, 
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proliferation, differentiation and apoptosis[23-26].  c-Myc, a proto-oncogene known to be 
over expressed in cancer situations, has been shown to control the activation of the CDK 
complexes. The important Wnt, Shh and EGF pathways are known activators of c-Myc, 
another example of c-Myc’s importance in cancer pathways. c-Myc deletion has also 
shown promise as a tissue specific form of cancer therapy.  c-Myc is a downstream player 
of the adenomatous polyposis coli (APC) tumor suppressor protein.  Loss of APC leads to 
the uncontrolled proliferation of epithelial intestinal cells. When c-Myc was deleted in 
APC deficient cells, normal cell proliferation was restored[27-28].  Interestingly, c-MYC has 
also been recently recognized to function cooperatively with transcription factors E2F1-3 
on processes such as cell proliferation and apoptosis[29-33].  There appears to be two 
canonical pathways that regulate cell proliferation, the Apc/Myc and the Rb/E2F pathways 
In vitro-derived data shows that the c-MYC/RB gene products may functionally 
antagonize one another in the control of cell proliferation. However, there is no clear data 
indicating the physiological relevance data explaining the connection.  Recent work by the 
Bremner and Leone groups shows that activation of Rb and downregulation of c-Myc 
expression are involved in regulating the cell’s exit from the division cycle. In order to 
observe the effects of these proteins on the cell cycle, this study examines epithelial cells 
of the murine gastrointestinal system. This organ has a distinct and well-organized crypt-
villus architecture that facilitates the study of proliferation and has a high cell turnover rate 
even in the adult mouse (Figure 3), important because some cell types such as nervous 
tissues stop dividing after a certain age[34].  The integrity of this structure is maintained by 
tight-controlled cell proliferation, differentiation and apoptosis.   
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It is clear that the Rb/E2f and c-Myc pathways are important for cell cycle control, 
and changes in their activity have been documented in many types of cancer.  There have 
also been studies that suggest cooperation between the two pathways, yet they are not well 
characterized in vivo and the molecular mechanism is not well understood.  Given the 
importance of these two pathways in carcinogenesis and suggestive evidence of their 
overlapping pathways, we have attempted to more concretely define the coordination 
between these two pathways in vivo.  
 
 
Figure 3[34]. Diagram of the small intestine crypt and villi structures.  Stem cells in the 
crypts provide the progenitor cells that will develop into the differentiated villi epithelium.  
These cells migrate up the villi until they are shed at the top.  The entire migration takes 
approximately 48-84 hours. 
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MATERIALS AND METHODS 
 
Mouse Strains and Genotyping 
All usage of mice has been approved by Institutional Animal Care and Use Committee at 
the Ohio State University.  Ah-cre transgenic mice were bred with mice containing floxed 
genes of interest to obtain desired genotypes.  Genotypes used in this study (Ah-cre, 
RbloxP/loxP, E2f1-/-, E2f2-/-, E2f3loxP/loxP, and MycloxP/loxP) were tested using DNA isolated 
from tail samples and amplified using standard PCR. Primers used for this study include: 
Ah-cre:  
Ah1-fwd CCT GAC TAG CAT GGC GAT AC,  
AhCre-2 ATT GCC CCT GTT TCA CTA TC.  
 
 
Rb:  
Rb18 GGC GTG TGC CAT CAA TG (WT) 
Rb19e CTC AAG AGC TCA GAC TCA TGG (WT)  
Rb212 GAA AGG AAA GTC AGG GAC ATT GGG (KO).  
 
E2f1:  
E2F1F AGC CAC TGG ATA TGA TTC TTG GAC (WT),  
E2F1R AGA AGT CAC GCT ATG AAA CCT CAC (WT),  
Neo AGT GCC AGC GGG GCT GCT AAA (KO).  
 
c-Myc:  
Myc 2 : AAT TTA AGC CTG ACC CCC GCG GCA (KO),  
3’flox : TAC AGT CCC AAA GCC CCA GCC AAG (WT),  
5’flox : CAC CGC CTA CAT CCT GTC CAT (WT). 
 
Cre recombinase was stimulated via intraperitoneal injection of β-naphthoflavone 
at 2 months with 5 injections over 30 hours.  The small intestine was harvested 2-5 days 
after the final injection, and either villi/crypt isolation performed or tissue fixation in 
formalin.  BrdU was injected intrperitoneally injected two hours prior to dissection. 
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RNA 
 RNA was purified from either intestinal epithelial or crypt cells using Trizol and 
cleaned with Qiagen RNA miniprep columns.  Microarray analysis was done by The Ohio 
State University Shared Resources Center using Affymetrix Mouse 30.2 chips.  
qRT-PCR 
cDNA was synthesized using RNA from isolated intestinal epithelium or crypt 
tissue and Invitrogen Supercript III Reverse Transcriptase Kit. qRT-PCR was performed 
using BIO-RAD iCycler with SYBR detection system.  All samples were analyzed in 
triplicate and flourecense measured relative to GAPDH. 
Staining 
 IHC and IF staining-Antibodies used for tissue staining: BrdU (Dako M0744), 
Phosphorylated Histone-3 (Millipore 06-570), Cleaved Caspase-3 (Cell Signaling, 9661L), 
Phosphorylated H2AX (Cell Signaling 9718P), Cyclin A2 (Santa Cruz sc-596), CDK1 
(Santa Cruz sc-54), Mcm3 (Santa Cruz sc-9850), Pcna (Santa Cruz sc-56).  Tissues used 
for staining were harvested and immediately fixed in formalin.  Slide preparation was done 
by the Leone Histology Lab.  
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RESULTS 
 
Loss of Either E2f1-3 or c-Myc Rescues Rb-deficiency 
To test whether E2f1-3 and c-Myc (herein noted as Myc) are performing similar 
functions in regulation of the cell cycle, we first tested if ablation c-Myc can rescue an Rb-
deficient cell similar to ablation of E2f1-3. Ah-cre transgenic mice were used for 
conditional knockout of genes of interest.  To stimulate Cre recombinase, β-
naphthoflavone was injected intraperitoneally and tissues harvested 2-5 days later.  
Deletion of Rb causes ectopic proliferation in the intestinal epithelium, without altering 
normal crypt division as observed using immunofluroescence detection of cell cycle 
markers BrdU and Phosphorylated Histone-3 (P-H3), (Fig. 4A,B). When E2f1-3 is deleted 
in Rb-deficient tissues, the ectopic proliferation in the epithelium is reduced, consistent 
with the current understanding of E2f1-3 functioning as downstream effectors of Rb.  
Interestingly, deletion of Myc also alleviated the ectopic proliferation caused by deletion of 
Rb (Fig. 4A,B).  
We then compared global gene expression to understand the basis of this genetic 
rescue.  Groups used were: β-NF treated control (Ctrl), Ah-cre RbloxP/loxP (RbKO), Ah-cre 
RbloxP/loxP E2f1-/- E2f2-/-E2f3loxP/loxP (Rb/E2f QKO) and Ah-cre RbloxP/loxP MycloxP/loxP (Rb/Myc 
DKO). Global gene expression levels were similar in the intestinal crypts between the four 
genetic groups. In the epithelial cells, Rb deletion corresponds to dramatic gene expression 
changes.  Many of the genes affected by Rb deletion were rescued by additional deletion of 
either E2f1-3 or Myc (data not shown). There was significant overlap between genes 
rescued by E2f1-3 deletion and genes rescued by Myc deletion.  Expression levels of these 
genes were validated using quantitative real-time PCR (qRT-PCR) (Fig. 4C).  
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A.        B. 
 
 
C. 
 
 
Figure 4.  Genetic rescue of Rb-deficiency.  A. Control, RbKO, Rb/Myc DKO, and 
Rb/E2f1-3 QKO intestinal slides were immunostained for BrdU(S-phase indicator) and P-
H3 (mitosis indicator). DAPI was used as a nuclear counter stain. B. Quantification of 
percent positive BrdU or P-H3 cells in either intestinal crypt or villi sections (n=4). C. 
Expression levels of G1/S genes via cDNA synthesized from RNA of purified intestinal 
villi cells, relative to GAPDH.     
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Simultaneous Deletion of E2f1-3 and Myc Results in Loss of Intestinal Homeostasis 
The rescue of an Rb-deficient phenotype by deletion of both E2f1-3 and Myc 
prompted us to investigate if there was any synergy between E2f1-3 and Myc.  To analyze 
if E2f1-3 and Myc coordinate cell cycle in vivo, we studied the affects of simultaneous 
deletion of both E2f1-3 and Myc on the small intestine epithelium.  While Ah-cre E2f1-/-
E2f2-/- E2f3loxP/loxP (E2f TKO) or Ah-cre MycloxP/loxP (MycKO) intestines looked similar to β-
NF treated control animals (Ctrl), simultaneous deletion of E2f1-3 and Myc in Ah-cre E2f1-
/- E2f2-/- E2f3loxP/loxP MycloxP/loxP (E2f/Myc QKO) tissues were marked with complete loss of 
intestinal homeostasis (Fig. 5A).  The disruption of the villi originates in the crypts 
because intact villi were observed in mice harvested one day after β-NF injection, while 
crypts progressively declined (Fig. 5E). 
In order to examine if disruption of the cell cycle was contributing to the declining number 
of crypt cells in E2f1-3/Myc QKO mice, immunofluorescence staining of S phase indicator 
BrdU and mitosis indicator P-H3 was performed (Fig. 5B,C).   DNA synthesis was 
unaffected in E2f1-3/Myc QKO crypts, but there was a drastic decline in the number of 
mitotic cells.  These results suggest that simultaneous deletion of E2f1-3 and Myc causes 
disruption of the G2/M transition, but not G1/S.   Upon higher magnification, E2f1-3/Myc 
QKO crypt cells appeared to be larger and the chromatin less dense than Ctrl crypts (Fig 
5D).   
To assess if other cellular processes were affected by E2f1-3/Myc deletion, 
immunohistochemistry staining of cleaved caspase-3 and phosphorylated-H2AX was done 
to examine apoptosis and double-strand DNA breaks, respectively.  Only E2f1-3 TKO 
crypts showed elevated apoptosis, whereas both Myc KO and E2f1-3/Myc QKO crypts 
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showed extremely low levels of apoptosis (Fig. 6). Upon examination of E2f1-3/Myc QKO 
crypts at earlier time points, apoptotic events were still rare, indicating that additional 
deletion of Myc did not cause apoptotic cells to be removed earlier. However, both E2f1-3 
TKO and E2f1-3/Myc QKO crypts stained positive for double-strand DNA breaks (Fig. 6). 
This data suggests that deletion of E2f1-3 is enough to initiate DNA damage and initiate 
the apoptosis program.  However, E2f1-3/Myc QKO crypts could not successfully carryout 
apoptosis because the simultaneous deletion of E2f1-3 with Myc caused arrest at mitosis 
and the corresponding checkpoint responses to DNA damage. It appears then that E2f1-3 
and Myc are not mandatory for proper G1/S phase transition in progenitor cells.  However, 
they both are vital for proper G2/M phase transition. 
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A. 
 
 
B.          C. 
 
 
D.        E. 
 
 
 
Figure 5.  Loss of epithelial homeostasis in E2f1-3/Myc QKO mice.  A. H&E stain of 
Control, E2f1-3 TKO, MycKO, and E2f1-3/Myc QKO intestine.  B. BrdU and P-H3 
immunostained slides of intestinal crypt sections. DAPI used as a nuclear counter stain. C. 
Quantification of perfect positive BrdU or P-H3 cells in crypt sections (n=3). D. High 
magnification H&E stain of Control and QKO crypts, respectively.  E. Quantification of 
average number of crypt cells per crypt in relation to genotype and time after injection of 
β-Naphthoflavone (n=2). 
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Figure 6.  Mitotic arrest and DNA damage in E2f1-3/Myc QKO mice. 
Immunofluorescence staining of Control, E2f1-3 TKO, MycKO, and E2f1-3/Myc QKO 
intestinal crypt sections.  DAPI used as a nuclear counter stain. 
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Combinatorial Transcriptional Regulation by E2f1-3 and Myc 
We have demonstrated that E2f1-3 and Myc cooperate on certain aspects of the cell 
cycle.   In order to understand pathway E2f1-3 and Myc follow to facilitate this 
cooperation, we performed a microarray to assess the global gene expression of β-NF 
treated control, E2f TKO, MycKO and E2f/Myc QKO intestinal crypt cells. There were four 
areas of genes which resulted in changes of gene expression levels (Fig. 7A): The first 
category are genes which saw changes in gene expression in E2f1-3 TKO, Myc KO, and 
E2f1-3/Myc QKO crypts, indicating they are regulated by both Myc and E2f1-3. The 
second and third group would be genes that were changed with either E2f1-3 or E2f1-
3/Myc deletion, and Myc or E2f1-3/Myc deletion.  These two groups would be said to be 
regulated by E2f1-3 or Myc, respectively.  The fourth group of genes would be the 
category where gene expression only changed with the simultaneous deletion of E2f1-3 
and Myc.  It is important to note that there is the possibility of genes being slightly 
misregulated in either the E2f1-3 TKO or Myc KO and greatly misregulated in the E2f1-
3/Myc QKO category, however only the statistically significant change in expression in the 
E2f1-3/Myc category was considered to be E2f1-3/Myc synergistic.  In order to validate the 
gene expression changes found in the microarray, mRNA isolated from β-NF treated 
control, E2f TKO, MycKO and E2f/Myc QKO intestinal crypt cells was used for reverse 
transcription and quantitative real-time PCR for a group of genes found in the fourth 
microarray category (Fig. 7C). There was a subset of G2/M genes (Ccnb1, Cdc2, Cdc20) 
that showed no changed in gene expression in the E2f1-3 TKO or Myc KO cells, and were 
down-regulated in the E2f1-3/Myc QKO cells.  Important G1/S transition genes (Pcna, 
Mcm3, Cdc6) were found to exhibit similar gene expression levels in all four genotypes.  
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Immunofluorescence for the G2/M subset of genes was done to show protein levels in the 
Ctrl, E2f1-3 TKO, Myc KO, and E2f1-3/Myc QKO crypts (Fig. 7B). The staining results 
recapitulate the results from the microarray and qRT-PCR, there is a unique subset of 
G2/M transition proteins that are misregulated with combinatorial deletion of E2f1-3 and 
Myc, resulting in a decrease of both mRNA and functional protein.  This data suggests that 
the G1/S transition is not affected by simultaneous deletion of E2f1-3 and Myc, other than 
the incurred DNA damage.  However, the G2/M transition relies on cooperation from both 
E2f1-3 and Myc. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   17	  
A. 
 
B. 
 
C. 
 
 
Figure 7.  Combinatorial regulation of transcriptional programs by E2f1-3 and Myc.   
A. Microarray results from cDNA synthesized from intestinal crypts (p<0.05). B. 
Expession levels via cDNA from purified intestinal crypt cells, relative to GAPDH. C. 
Immunofluorescence staining of intestinal crypts. DAPI used as a nuclear counter stain. 
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DISCUSSION 
This study aimed to investigate the functional interaction between two well-
characterized transcriptional pathways in the context of cell cycle control.  The Rb/E2f 
pathway has long been known to be essential for proper G1/S phase transition, and the E2f 
family has been shown to be important activators and repressors of cellular activities.  The 
c-Myc oncogene has also been shown to be a vital activator of cellular growth, 
differentiation, and apoptosis.  Rb, E2f, and c-Myc have all been identified to be 
misregulated in many types of cancers, adding to their importance in regulation of the cell 
cycle.  Despite the vast knowledge of these proteins, the understanding of their cooperation 
is lacking. 
In this paper, we have shown that Myc and E2f1-3 are essential for proper cell cycle 
control and intestinal cpithelium homeostasis.  From this, we demonstrate that E2f1-3 and 
Myc have distinct, yet overlapping transcriptional networks they regulate.  A key area of 
synergy identified for E2f1-3 and Myc is the G2/M phase transition in intestinal crypt cells.  
Simultaneous deletion of E2f1-3 and Myc results in DNA damage, arrest of mitosis, and 
failure of apoptosis, which results in atrophic intestinal villi.     
In an Rb-deficient context, deletion of either E2f1-3 or Myc is sufficient to rescue 
ectopic cellular proliferation in the intestinal villi.  Because the rescued epithelium exhibits 
close to normal DNA synthesis and cell division, E2f1-3 and Myc are important in 
activating both G1/S and G2/M phase transitions.  This suggests that in a cancer context, or 
loss of a tumor supressor, both E2f1-3 and Myc are activating ectopic cell proliferation.  In 
both cases, the E2f1-3 and Myc transcriptional networks clearly overlap more than 
originally thought.  This knowledge is extremely important in the fight to cure cancer 
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because cancer is defined by misregulation of transcriptional pathways.  Unless researchers 
are able to clearly connect transcriptional targets in the interlocking pathways already 
characterized, we will not ble able to fully understand the process of carcinogenesis, nor 
will researchers be able to create effective plans of early detection and treatment without 
all the dots on the cancer map connected.  
While we have shown that E2f1-3 and Myc cooperate to regulate certain cellular 
processes, the molecular mechanism by which they regulate the activation of those 
pathways is yet to be determined.  To do this, chromosomal immunoprecipitation 
sequencing (ChIP-seq) could be used to identify the DNA binding loci of given 
transcription factors.  By fixing DNA/protein complexes in the intestinal epithelium with 
formaldehyde, we will be able to pull down sequences bound directly by either c-Myc or 
the E2f activators.  Once the complexes are isolated and the DNA fragments amplified and 
sequenced, we will be able to analyze the direct targets of Myc and E2f1-3 in the intestinal 
epithelium.  We hypothesize that a subset of the E2f1-3/Myc synergistic genes obtained by 
the microarray will be direct targest of both E2f1-3 and Myc. This would suggest that E2f1-
3 and Myc co-regulate a subset of genes by direct binding to their DNA sequences.  If this 
is the case, this knowledge would help define the interaction between two important 
trasncription factors in vivo both in a normal and Rb-deficient (cancer) context.   
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